Abiraterone
NDC 68001-673, Abiraterone Acetate, tablet, from BluePoint Laboratories.
- Product NDC
- 68001-673
- Status
- Listed
- Labeler
- BluePoint Laboratories
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA210686
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68001-673 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ABIRATERONE ACETATE500 mg/1
Pharmacologic classes
Cytochrome P450 17A1 Inhibitor [EPC]; Cytochrome P450 17A1 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68001-673-06 | 68001067306 | 60 TABLET in 1 BOTTLE (68001-673-06) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/32f6b83d-c743-4934-9a20-1b5bf9f4eea3NADAC price for package 68001067306
GET /v1/drugs/nadac/68001067306
Use it
Look up 68001-673 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68001-673 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68001-673. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.